Next Article in Journal
Tourism-Based Alternative Livelihoods for Small Island Communities Transitioning towards a Blue Economy
Previous Article in Journal
Design of Capacitive Bridge Fault Current Limiter for Low-Voltage Ride-Through Capacity Enrichment of Doubly Fed Induction Generator-Based Wind Farm
 
 
Article

Life-Cycle Assessment of the Breezhaler® Breath-Actuated Dry Powder Inhaler

1
Novartis Pharma AG, 4056 Basel, Switzerland
2
ERM, Manchester M5 3EF, UK
*
Author to whom correspondence should be addressed.
Academic Editor: João Carlos de Oliveira Matias
Sustainability 2021, 13(12), 6657; https://doi.org/10.3390/su13126657
Received: 20 April 2021 / Revised: 3 June 2021 / Accepted: 4 June 2021 / Published: 11 June 2021
(This article belongs to the Topic Industrial Engineering and Management)
The Breezhaler® dry powder inhaler (DPI) has a low carbon footprint compared with other inhalation therapies, consistent with the literature on other DPIs. This life-cycle assessment was conducted in France, Germany, the UK, and Japan using a “cradle-to-grave” technique to evaluate six environmental impact categories (global warming potential; acidification; ozone depletion; use of resource, minerals, and metals; eco-toxicity; and freshwater use) associated with the use of the Breezhaler®. Three variants of the Breezhaler® (30-day packs with and without the digital companion and a 90-day pack without the digital companion) were evaluated to identify major hotspots in the device life-cycle and to provide realistic solutions to reduce the environmental impact. Although no single life-cycle stage dominated the climate change impact of the 30-day device with the digital companion, the inhaler’s raw materials and packaging contributed to 96% of the resource depletion impact for the 30-day device without the digital companion. For the 90-day device without the digital companion, packaging contributed 42–62% of the impact across all categories. Overall, the Breezhaler® inhaler with the 90-day pack had the lowest environmental impact. The environmental impact of the device did not vary significantly among the considered markets. Further studies are needed to assess the impact of active pharmaceutical ingredients and improvement in clinical outcomes on the environment. View Full-Text
Keywords: Breezhaler® respiratory inhaler; life-cycle assessment; environmental impact; cradle-to-grave Breezhaler® respiratory inhaler; life-cycle assessment; environmental impact; cradle-to-grave
Show Figures

Figure 1

MDPI and ACS Style

Fulford, B.; Mezzi, K.; Whiting, A.; Aumônier, S. Life-Cycle Assessment of the Breezhaler® Breath-Actuated Dry Powder Inhaler. Sustainability 2021, 13, 6657. https://doi.org/10.3390/su13126657

AMA Style

Fulford B, Mezzi K, Whiting A, Aumônier S. Life-Cycle Assessment of the Breezhaler® Breath-Actuated Dry Powder Inhaler. Sustainability. 2021; 13(12):6657. https://doi.org/10.3390/su13126657

Chicago/Turabian Style

Fulford, Brett, Karen Mezzi, Andy Whiting, and Simon Aumônier. 2021. "Life-Cycle Assessment of the Breezhaler® Breath-Actuated Dry Powder Inhaler" Sustainability 13, no. 12: 6657. https://doi.org/10.3390/su13126657

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop